Introduction
Phenylpropanoids, which include stilbenoids, flavonoids, curcuminoids, and cinnamyl anthranilate, are a diverse group of secondary metabolites synthesized from L-phenylalanine or L-tyrosine. These compounds exhibit different bioactivities including antioxidant, antiviral, antibacterial, and anticancer (1-3). Thus, phenylpropanoids are widely used in pharmaceuticals, cosmetics, and food supplements. With the rapid development of market demands, phenylpropanoid supply is facing new opportunities and challenges (4) . Phenylpropanoids are traditionally acquired through phytoextraction from mosses or angiosperms (5) (6) (7) . However, the extraction yield of these compounds can hardly exceed 1% of the dry weight (8) . Recently, synthetic biologists have attempted to explore biological phenomena and natural product synthesis by artificial-biological systems (9) . Phenylpropanoids biosynthesis in recombinant Escherichia coli and Saccharomyces cerevisiae has achieved great progress, especially the biosynthesis of several bioactive compounds such as caffeic acid (10) , naringenin (11, 12) , anthocyanin (13) , resveratrol (14) , pinocembrin (15, 16) , pinosylvin (17) , and styrene (18) by engineered E. coli fermentation. E. coli, which is the most genetically tractable microbial host, has been used as a microbial factory for the artificial biosynthesis of different types of molecules (19) . The engineering strategy for the biosynthetic pathway of phenylpropanoids in microorganisms is shown in Fig. 1 . This strategy involves embedding phenylalanine ammonia lyase (PAL) or tyrosine ammonia lyase (TAL) to convert endogenous/extrinsic L -phenylalanine into trans-cinnamic acid or L-tyrosine into p-coumaric acid. Different pivotal enzymes then convert trans-cinnamic acid or p-coumaric acid into different phenylpropanoids.
So far, the development of phenylpropanoid biosynthesis in E. coli is limited by some problems. Firstly, trans-cinnamic acid or pcoumaric acid is usually used as the starting precursor to produce phenylpropanoids because of the low turnover numbers of the reaction catalyzed by PAL or TAL, but the cost is more than that incurred using amino acids. Therefore, producing phenylpropanoids from L-tyrosine/L-phenylalanine or a carbon source has attracted the attention of academic and industrial researchers. Secondly, expression system inducers such as isopropyl-β-D-1-thiogalactopyranoside (IPTG) are toxic and unsuitable for the industrial production of phenylpropanoids. By contrast, constitutive expression systems are appropriate for industrial needs. Such systems can be actively induced by the carbon source during fermentation and allow the continuous transcription of heterogeneous genes. For instance, the promoter of the glyceraldehyde-3-phosphate dehydrogenase gene (pGAP) system has been successfully used to produce transresveratrol in engineered E. coli (14) . Thirdly, different strains with different expression vectors have different effects (20, 21) . BioBrick assembly parts such as different ribosomal binding sites (RBSs), replication regions, promoters, terminators, and polycistronic transcriptional assemblies are also limiting factors that need to be resolved (22) .
In this study, the Rhodotorula glutinis RgPAL/TAL enzyme, which has dual substrate specificity and high enzymatic activity in E. coli (23), was selected for heterogeneous expression. The kinetic analyses were conducted using L-phenylalanine and L-tyrosine as substrates to explore the substrate preference of RgPAL/TAL. The constitutive expression, BioBrick assembly, and strain were optimized to biosynthesize trans-cinnamic acid and p-coumaric acid in E. coli. To the best of our knowledge, this is the first to explore the possibility of using a constitutive expression system for phenylpropanoic acid precursor bioproduction in E. coli. Moreover, this synthetic process may be further used for industrial food bioproduction of phenylpropanoids in E. coli.
Materials and Methods
Reagents, chemicals, and strains E. coli DH5α was used for plasmid cloning. E. coli ATCC31884 and other strains (Table 1) were used for recombinant molecule production. R. glutinis GIM2.156 was used for total RNA isolation. PrimeScript reverse transcription polymerase chain reaction (RT-PCR) kit, ExTaq polymerase, vector plasmid pMD18-T, restriction enzymes, and T4 DNA ligase were purchased from Takara Biochemicals Inc, Dalian, China. Vector plasmids pQE-30 and pREP4 were purchased from Qiagen Inc, Shanghai, China. DNA plasmids were prepared from stock strains using a Tiangen plasmid miniprep kit, Beijing, China. DNA fragments were isolated through gel extraction using a Tiangen gel DNA recovery kit (Tiangen Biotech Co., Ltd., Beijing, China). L-tyrosine, L-phenylalanine, trans-cinnamic acid, and p-coumaric acid standards were purchased from SigmaAldrich (St. Louis, MO, USA).
RgPAL/TAL complementary DNA (cDNA) cloning Total RNA was extracted in accordance with the hot phenol method. The first-strand cDNA of RgPAL/TAL was synthesized by using the PrimeScript RT-PCR kit in accordance with the manufacturer's protocol. The pF_PAL/ TAL_clone and pR_PAL/TAL_clone specific primers listed in Table 1 , based on existing PAL sequences (Genebank entry KF770992), were used to amplify the complementary strand. The RT-PCR products were purified and ligated into the pMD18-T vector to generate pMD18-RgPAL/TAL for sequencing.
Expression plasmid construction Plasmid pMD18-pGAP was provided by Bioengineering Laboratory stocks. The gap promoter (pGAP) was cloned from pMD18-pGAP. The rrnB T1 terminator was cloned from pQE-30. RgPAL/TAL was cloned from pMD18-RgPAL/ TAL. The total RgPAL/TAL operon (fusion of three DNA fragments) was amplified through touchdown overlap extension PCR. Different sequences of RBS were added using specific primers. Different RgPAL/TAL operon fragments were digested by HindIII and XbaI and independently inserted to the HindIII/XbaI site of pQE-30 or pREP4. 
Laboratory preservation
Laboratory preservation E. coli M15 Host strain for QIA expression system Qiagen Inc. All constructed plasmids were verified via colony PCR and sequencing. All plasmids, primers, and RBS sequences are listed in Table 1 .
Protein purification and in vitro assays E. coli BL21 (DE3) harboring the expression vector pET-32a-RgPAL/TAL was grown at 37 Phenylpropanoic acid precursor bioproduction analysis All samples extracted from the cultures were centrifuged at 13,000×g (micro liter rotor size: 24×2 mL) for 5 min. The supernatants were analyzed on an HPLC system with a phenomenex ODS reversed-phase C-18 column (5 µm, 250×4.6 mm) and an LC2030 UV Detector. The solvent profile was acetonitrile (buffer A) and 0.1% (v/v) acetic acid in water (buffer B) as mobile phases with a flow rate of 1.0 mL/min. The injection volume was 20 µL. For p-coumaric acid, trans-cinnamic acid, and trans-resveratrol detection, the samples were separated with the mobile-phase composition profile fixed at 35% buffer A/65% buffer B and 50% buffer A/50% buffer B, respectively. The characteristic UV absorption spectra of the samples were 308 nm and 272 nm, respectively. The metabolites were confirmed by comparing their retention times with those of authentic standards (i.e., 4.847 and 5.560 min).
Results and Discussion
Identifying the best constitutive BioBrick combination for phenylpropanoic acid precursor bioproduction in E. coli BioBricks are originally defined as DNA sequences that conform to a restrictionenzyme assembly standard; these sequences contain a combination of a promoter, RBS, operon, terminator, and plasmid backbone. In bacteria, RBS is an effective control element for translation (24) , and thereby, protein expression. The replication region determines the copy number of vectors and the expression level of heterogeneous genes. So we hoped for the increasing accumulation of phenylpropanoic acid precusors via BioBrick combinatorial optimization.
In this study, five constitutive expression vectors with different RBSs and replication regions were constructed and transferred into E. coli MG1665 for shake flask studies. The supernatant of the cultured broth was analyzed via HPLC. A peak was detected at the same retention time of trans-cinnamic acid and p-coumaric acid standards, whereas no peak appeared in the corresponding HPLC chromatogram in the negative control (Fig. 2) .
As shown in Table 2 , when 1 mM L-phenylalanine or L-tyrosine was used as a substrate, the maximum titer of trans-cinnamic acid and pcoumaric acid was detected in the strain MGTBS1. With the same RBS, the production of the strain with the pBR322 replication region (moderate copy number) plasmid was higher than the strain with the p15A replication region (low copy number) plasmid and the mpMB1 replication region (high copy number) plasmid. This result may be related to the fact that the low-copy plasmid was more stable than the high-copy vector and the plasmid-specific expression of the lowcopy plasmid was higher than the high-copy plasmid (25) . The production of the strain with the strong RBS (RBS of pET32a) plasmid was higher than the strain with the weak RBS (RBS of gpd in E. coli) plasmid (comparison between MGTAL1 and MGTBS1 with the same replication region) because the strong RBS plasmid utilized ribosomal binding and transcriptional initiation. Therefore, different BioBrick compositions directly influenced the titers of metabolic production. We decided to use the strong RBS plasmid with moderate copy number constructs (pTBS1) for further experiments.
Determining the best strain for phenylpropanoic acid precursor biosynthesis For different strain selection, we investigated pTBS1 in eight general lab strains and observed strain-to-strain variations in p-coumaric acid and trans-cinnamic acid titers (Fig. 3A) . When 1 mM L-phenylalanine or L-tyrosine was used as the substrate, the strain ATTBS1 produced higher yields of p-coumaric acid and trans-cinnamic acid in comparison with other strains, and the maximum yield was 3.6-and 7.4-fold the minimum yield (when compared with strains ATTBS1 and MCTBS1), respectively. These results demonstrate that the different strains had varied capacities for phenylpropanoic acid precursor biosynthesis. The preferable metabolic capability of E. coli ATCC31884 cells may be associated with its developed shikimic acid metabolism.
Next, we explored the capacities of phenylpropanoic acid precursor biosynthesis in the engineered strain ATTBS1 by shake flask culturing with no substrate added. As shown in Fig. 3B , the accumulation of pcoumaric acid/trans-cinnamic acid and the value of OD 600 were detected at different times. The production of p-coumaric acid continuously increased before 36 h. The highest yield of p-coumaric acid was 34.67±3.71 mg/L, but this amount decreased after 36 h. During cultivation, trans-cinnamic acid was also detected and the RBS1 is RBS of gpd in E. coli, RBS2 is RBS of pET-32a system.
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titer of production continuously increased before 60 h. The highest yield of trans-cinnamic acid was 78.81±4.96 mg/L, but this amount decreased after 60 h. The OD 600 obviously decreased after 24 h possibly because of the growth inhibition by p-coumaric acid and trans-cinnamic acid. These results highlight that we have successfully evolved an E. coli strain that is able to produce a phenylpropanoic acid precursor from its shikimic acid metabolism without any additive toxic inducers or amino acids. Increasing the production of L-tyrosine/L-phenylalanine is an effective and feasible strategy for the improvement of pcoumaric acid/trans-cinnamic acid biosynthesis. Recent studies have used genetically engineered E. coli for L-tyrosine/L-phenylalanine overproduction (26, 27) . This expression system can be used for these engineered E. coli and can facilitate the low-cost direct production of phenylpropanoids.
Moreover, to change the proportion of L-tyrosine/L-phenylalanine according to the need of synthesis by nitrogen source regulation in the culture medium was another process for product enhancement (28) .
Characterization analysis of RgPAL/TAL We explored the substrate preference of RgPAL/TAL by a kinetic study to explain why the titer amount of trans-cinnamic acid is higher than that of p-coumaric acid. A kinetic study of RgPAL/TAL was conducted with L-tyrosine and Lphenylalanine as substrates. As shown in Table 3 , K m of RgPAL/TAL for L-tyrosine (0.55±0.04 mM) was lower than that of L-phenylalanine. This result indicates that RgPAL/TAL exhibits a higher affinity toward L-tyrosine than L-phenylalanine. However, k cat /K m of RgPAL/TAL was significantly greater for L-phenylalanine than for L-tyrosine. This result is consistent with previous research (23, 29) . However, the main strategy of synthetic bioengineering for phenylpropanoid biosynthesis is to use p-coumaric acid as the initial substrate rather than transcinnamic acid. Trans-cinnamic acid can be transformed into pcoumaric acid via cinnamate 4-hydroxylase (C4H), a P450 enzyme, and cannot be effectively expressed in E. coli (30) (31) (32) . L-tyrosine can be directly converted into p-coumaric acid under the catalysis of TAL, thereby avoiding the C4H pathway. Consequently, TAL is suitable for phenylpropanoid biosynthesis in E. coli to establish a high conversion platform. Codon optimization of the tal gene had a good effect on pcoumaric acid production (10, 33) . Engineering an E. coli strain that overproduces L-tyrosine can increase the yield of phenylpropanoids through vast substrate accumulation (10) . Rational enzyme reconstruction or highly active and specific TAL screening can also improve the catalytic efficiency (34); thus, this process needs to be performed in the future. All values are the average from three independent experiments. Values within column followed by the same letter are not significantly different at p<0.05.
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